CV 205-502 TREATMENT OF HYPERPROLACTINEMIA

被引：50

作者：

VANCE, ML

CRAGUN, JR

REIMNITZ, C

CHANG, RJ

RASHEF, E

BLACKWELL, RE

MILLER, MM

MOLITCH, ME

机构：

[1] UNIV CALIF DAVIS, DEPT OBSTET & GYNECOL, DAVIS, CA 95616 USA

[2] UNIV CALIF LOS ANGELES, DEPT OBSTET & GYNECOL, LOS ANGELES, CA 90024 USA

[3] UNIV ALABAMA, DEPT OBSTET & GYNECOL, BIRMINGHAM, AL 35294 USA

[4] NORTHWESTERN UNIV, DEPT OBSTET & GYNECOL, CHICAGO, IL 60611 USA

[5] NORTHWESTERN UNIV, CTR ENDOCRINOL METAB & NUTR, CHICAGO, IL 60611 USA

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1989年 / 68卷 / 02期

关键词：

D O I：

10.1210/jcem-68-2-336

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：336 / 339

页数：4

共 12 条

[1] SIZE-REDUCTION OF MACROPROLACTINOMAS BY BROMOCRIPTINE OR LISURIDE TREATMENT [J].

CHIODINI, P ;

LIUZZI, A ;

COZZI, R ;

VERDE, G ;

OPPIZZI, G ;

DALLABONZANA, D ;

SPELTA, B ;

SILVESTRINI, F ;

BORGHI, G ;

LUCCARELLI, G ;

RAINER, E ;

HOROWSKI, R .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (04) :737-743

[2]

HUMPEL M, 1983, LISURIDE OTHER DOPAM, P141

[3] HYPERPROLACTINEMIA - LONG-TERM EFFECTS OF BROMOCRIPTINE [J].

JOHNSTON, DG ;

PRESCOTT, RWG ;

KENDALLTAYLOR, P ;

HALL, K ;

CROMBIE, AL ;

HALL, R ;

MCGREGOR, A ;

WATSON, MJ ;

COOK, DB .

AMERICAN JOURNAL OF MEDICINE, 1983, 75 (05) :868-874

[4] REDUCTION IN SIZE OF PROLACTIN-SECRETING TUMORS IN MEN TREATED WITH PERGOLIDE [J].

KENDALLTAYLOR, P ;

HALL, K ;

JOHNSTON, DG ;

PRESCOTT, RWG .

BRITISH MEDICAL JOURNAL, 1982, 285 (6340) :465-467

[5] PERGOLIDE FOR THE TREATMENT OF PITUITARY-TUMORS SECRETING PROLACTIN OR GROWTH-HORMONE [J].

KLEINBERG, DL ;

BOYD, AE ;

WARDLAW, S ;

FRANTZ, AG ;

GEORGE, A ;

BRYAN, N ;

HILAL, S ;

GREISING, J ;

HAMILTON, D ;

SELTZER, T ;

SOMMERS, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (12) :704-709

[6] LOW-DOSES OF DOPAMINE AGONISTS IN THE LONG-TERM TREATMENT OF MACROPROLACTINOMAS [J].

LIUZZI, A ;

DALLABONZANA, D ;

OPPIZZI, G ;

VERDE, GG ;

COZZI, R ;

CHIODINI, P ;

LUCCARELLI, G .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (11) :656-659

[7] BROMOCRIPTINE AS PRIMARY THERAPY FOR PROLACTIN-SECRETING MACROADENOMAS - RESULTS OF A PROSPECTIVE MULTICENTER STUDY [J].

MOLITCH, ME ;

ELTON, RL ;

BLACKWELL, RE ;

CALDWELL, B ;

CHANG, RJ ;

JAFFE, R ;

JOPLIN, G ;

ROBBINS, RJ ;

TYSON, J ;

THORNER, MO .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (04) :698-705

[8] LONG-TERM TREATMENT OF GALACTORRHEA AND HYPOGONADISM WITH BROMOCRIPTINE [J].

THORNER, MO ;

MCNEILLY, AS ;

HAGAN, C ;

BESSER, GM .

BRITISH MEDICAL JOURNAL, 1974, 2 (5916) :419-422

[9] A BROAD-SPECTRUM OF PROLACTIN SUPPRESSION BY BROMOCRIPTINE IN HYPERPROLACTINEMIC WOMEN - A STUDY OF SERUM PROLACTIN AND BROMOCRIPTINE LEVELS AFTER ACUTE AND CHRONIC ADMINISTRATION OF BROMOCRIPTINE [J].

THORNER, MO ;

SCHRAN, HF ;

EVANS, WS ;

ROGOL, AD ;

MORRIS, JL ;

MACLEOD, RM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (06) :1026-1033

[10] PSYCHOTIC REACTIONS DURING TREATMENT OF PITUITARY-TUMORS WITH DOPAMINE AGONISTS [J].

TURNER, TH ;

COOKSON, JC ;

WASS, JAH ;

DRURY, PL ;

PRICE, PA ;

BESSER, GM .

BRITISH MEDICAL JOURNAL, 1984, 289 (6452) :1101-1103

← 1 2 →